Last reviewed · How we verify
NCT07014475
Efficacy of the Ranger Drug-Coated Balloon in Treating BTK Lesions in Patients With CLTI
trial testing drug-coated balloon in Chronic Limb Threatening Ischemia in 700 participants. Not yet recruiting.
30 June 2028
Quick facts
| Lead sponsor | First Affiliated Hospital, Sun Yat-Sen University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 700 |
| Start date | 30 June 2025 |
| Primary completion | 30 June 2028 |
| Estimated completion | 1 January 2029 |
| Sites | 1 location across China |
Drugs / interventions tested
- drug-coated balloon
Conditions studied
- Chronic Limb Threatening Ischemia — all drugs for Chronic Limb Threatening Ischemia →
Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Who can join
18 and older, any sex, with Chronic Limb Threatening Ischemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, multicenter, observational study designed to evaluate the clinical outcomes of the Ranger™ SL paclitaxel-coated balloon, a type of drug-coated balloon (DCB), in the treatment of below-the-knee (BTK) lesions in patients with chronic limb-threatening ischemia (CLTI) in China. All enrolled patients will be followed for six months. Patients diagnosed with CLTI who undergo treatment with the Ranger DCB will be included in the study. The primary outcome is the incidence of major adverse events (MAEs).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07014475
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of drug-coated balloon
Trials testing the same drug.
- NCT07162792 — The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT · NA · not yet recruiting
- NCT06104033 — Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease · recruiting
- NCT05616520 — Treatment of Complex Femoropopliteal Artery Lesions Using Drug-coated PTA Balloon · unknown
- NCT05550233 — Drug-coated Balloons in Big de Novo Coronary Disease · NA · unknown
- NCT04778969 — Kor PCI - CAD Patients Treated With PCI: Analysis of the Korean Nationwide Health Insurance Database · unknown
Other recruiting trials for Chronic Limb Threatening Ischemia
Currently open trials in the same condition.
- NCT07068789 — Revascularization of Single Vesrus Multiple Infrapopliteal Vessels in Chronic Limb Threatening Ischemia · NA · recruiting
- NCT05786001 — Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia · recruiting
- NCT05553509 — Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection with Borderline Vascularity · active not recruiting
- NCT05620095 — Durg Coated Balloon Angioplasty in Infrapopliteal Lesions · recruiting
Other First Affiliated Hospital, Sun Yat-Sen University trials
Trials by the same sponsor.
- NCT07322835 — Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China · not yet recruiting
- NCT07322848 — DEB-TACE vs cTACE in HCC After TIPS · Phase 3 · recruiting
- NCT07087418 — AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases · recruiting
- NCT06951334 — Clinical Trial of Vildagliptin in Early Parkinson's Disease · NA · not yet recruiting
- NCT06929819 — Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07014475 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital, Sun Yat-Sen University
- Last refreshed: 11 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07014475.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing